Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: A multicentre, randomised, double-blind, phase III trial

S. M. Yim, J. H. Ko, Y. W. Lee, H. W. Kim, J. Y. Lee, N. I. Kim, Young Chul Kye, K. C. Park, J. H. Choi, K. H. Lee, M. N. Kim, K. J. Kim, Y. S. Ro, K. J. Ahn

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because of its large molecular weight and strong hydrophilic property. This study is a multicentre, double-blind, randomised, non-inferiority study to compare the antifungal effect and safety of fluconazole cream 0.5% and 1% with flutrimazole cream 1% in superficial mycosis. A total of 162 subjects selected to participate in this study were equally divided into three groups and assigned to be given fluconazole cream 0.5%, fluconazole cream 1%, and flutrimazole cream 1% in the ratio of 1: 1. The primary index of drug efficacy was determined by complete mycological cure in which no fungus was detected on KOH smear test 4 weeks after application of fluconazole. The secondary index of efficacy was defined as complete mycological cure 4 weeks after the application of fluconazole, improvement of clinical symptoms and overall effectiveness assessed by the research staff. According to this study, on comparing the efficacy of cure of superficial dermatomycosis after 4 weeks of application, both fluconazole 0.5% and fluconazole 1% cream were found to be equally effective and non-inferior to flutrimazole 1% cream. Given the effectiveness and safety of the drug, both fluconazole 0.5% and 1% cream might be said to be optimal concentration in the treatment of superficial dermatomycosis.

Original languageEnglish
Pages (from-to)522-529
Number of pages8
JournalMycoses
Volume53
Issue number6
DOIs
Publication statusPublished - 2010 Nov 1

Fingerprint

flutrimazole
Mycoses
Fluconazole
Safety
Dermatomycoses
Therapeutics
Pharmaceutical Preparations
Azoles

Keywords

  • Fluconazole cream
  • Flutrimazole Cream
  • Randomised Controlled Trial
  • Superficial Mycosis

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis : A multicentre, randomised, double-blind, phase III trial. / Yim, S. M.; Ko, J. H.; Lee, Y. W.; Kim, H. W.; Lee, J. Y.; Kim, N. I.; Kye, Young Chul; Park, K. C.; Choi, J. H.; Lee, K. H.; Kim, M. N.; Kim, K. J.; Ro, Y. S.; Ahn, K. J.

In: Mycoses, Vol. 53, No. 6, 01.11.2010, p. 522-529.

Research output: Contribution to journalArticle

Yim, S. M. ; Ko, J. H. ; Lee, Y. W. ; Kim, H. W. ; Lee, J. Y. ; Kim, N. I. ; Kye, Young Chul ; Park, K. C. ; Choi, J. H. ; Lee, K. H. ; Kim, M. N. ; Kim, K. J. ; Ro, Y. S. ; Ahn, K. J. / Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis : A multicentre, randomised, double-blind, phase III trial. In: Mycoses. 2010 ; Vol. 53, No. 6. pp. 522-529.
@article{346aa6773411476fa51c930c3d626c5a,
title = "Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: A multicentre, randomised, double-blind, phase III trial",
abstract = "Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because of its large molecular weight and strong hydrophilic property. This study is a multicentre, double-blind, randomised, non-inferiority study to compare the antifungal effect and safety of fluconazole cream 0.5{\%} and 1{\%} with flutrimazole cream 1{\%} in superficial mycosis. A total of 162 subjects selected to participate in this study were equally divided into three groups and assigned to be given fluconazole cream 0.5{\%}, fluconazole cream 1{\%}, and flutrimazole cream 1{\%} in the ratio of 1: 1. The primary index of drug efficacy was determined by complete mycological cure in which no fungus was detected on KOH smear test 4 weeks after application of fluconazole. The secondary index of efficacy was defined as complete mycological cure 4 weeks after the application of fluconazole, improvement of clinical symptoms and overall effectiveness assessed by the research staff. According to this study, on comparing the efficacy of cure of superficial dermatomycosis after 4 weeks of application, both fluconazole 0.5{\%} and fluconazole 1{\%} cream were found to be equally effective and non-inferior to flutrimazole 1{\%} cream. Given the effectiveness and safety of the drug, both fluconazole 0.5{\%} and 1{\%} cream might be said to be optimal concentration in the treatment of superficial dermatomycosis.",
keywords = "Fluconazole cream, Flutrimazole Cream, Randomised Controlled Trial, Superficial Mycosis",
author = "Yim, {S. M.} and Ko, {J. H.} and Lee, {Y. W.} and Kim, {H. W.} and Lee, {J. Y.} and Kim, {N. I.} and Kye, {Young Chul} and Park, {K. C.} and Choi, {J. H.} and Lee, {K. H.} and Kim, {M. N.} and Kim, {K. J.} and Ro, {Y. S.} and Ahn, {K. J.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1111/j.1439-0507.2009.01738.x",
language = "English",
volume = "53",
pages = "522--529",
journal = "Mycoses",
issn = "0933-7407",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis

T2 - A multicentre, randomised, double-blind, phase III trial

AU - Yim, S. M.

AU - Ko, J. H.

AU - Lee, Y. W.

AU - Kim, H. W.

AU - Lee, J. Y.

AU - Kim, N. I.

AU - Kye, Young Chul

AU - Park, K. C.

AU - Choi, J. H.

AU - Lee, K. H.

AU - Kim, M. N.

AU - Kim, K. J.

AU - Ro, Y. S.

AU - Ahn, K. J.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because of its large molecular weight and strong hydrophilic property. This study is a multicentre, double-blind, randomised, non-inferiority study to compare the antifungal effect and safety of fluconazole cream 0.5% and 1% with flutrimazole cream 1% in superficial mycosis. A total of 162 subjects selected to participate in this study were equally divided into three groups and assigned to be given fluconazole cream 0.5%, fluconazole cream 1%, and flutrimazole cream 1% in the ratio of 1: 1. The primary index of drug efficacy was determined by complete mycological cure in which no fungus was detected on KOH smear test 4 weeks after application of fluconazole. The secondary index of efficacy was defined as complete mycological cure 4 weeks after the application of fluconazole, improvement of clinical symptoms and overall effectiveness assessed by the research staff. According to this study, on comparing the efficacy of cure of superficial dermatomycosis after 4 weeks of application, both fluconazole 0.5% and fluconazole 1% cream were found to be equally effective and non-inferior to flutrimazole 1% cream. Given the effectiveness and safety of the drug, both fluconazole 0.5% and 1% cream might be said to be optimal concentration in the treatment of superficial dermatomycosis.

AB - Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because of its large molecular weight and strong hydrophilic property. This study is a multicentre, double-blind, randomised, non-inferiority study to compare the antifungal effect and safety of fluconazole cream 0.5% and 1% with flutrimazole cream 1% in superficial mycosis. A total of 162 subjects selected to participate in this study were equally divided into three groups and assigned to be given fluconazole cream 0.5%, fluconazole cream 1%, and flutrimazole cream 1% in the ratio of 1: 1. The primary index of drug efficacy was determined by complete mycological cure in which no fungus was detected on KOH smear test 4 weeks after application of fluconazole. The secondary index of efficacy was defined as complete mycological cure 4 weeks after the application of fluconazole, improvement of clinical symptoms and overall effectiveness assessed by the research staff. According to this study, on comparing the efficacy of cure of superficial dermatomycosis after 4 weeks of application, both fluconazole 0.5% and fluconazole 1% cream were found to be equally effective and non-inferior to flutrimazole 1% cream. Given the effectiveness and safety of the drug, both fluconazole 0.5% and 1% cream might be said to be optimal concentration in the treatment of superficial dermatomycosis.

KW - Fluconazole cream

KW - Flutrimazole Cream

KW - Randomised Controlled Trial

KW - Superficial Mycosis

UR - http://www.scopus.com/inward/record.url?scp=77958085967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958085967&partnerID=8YFLogxK

U2 - 10.1111/j.1439-0507.2009.01738.x

DO - 10.1111/j.1439-0507.2009.01738.x

M3 - Article

C2 - 19558428

AN - SCOPUS:77958085967

VL - 53

SP - 522

EP - 529

JO - Mycoses

JF - Mycoses

SN - 0933-7407

IS - 6

ER -